CareSource to Offer More Medicare Advantage Options in Kentucky
/
Date10 Oct 2016
DAYTON, Ohio and LOUISVILLE, Ky., Oct. 10, 2016 (GLOBE NEWSWIRE) — CareSource, a non-profit health plan, announces that its Medicare Advantage plan service area in... Read More →
CareSource to Offer More Hoosiers Medicare Advantage Options
/
Date10 Oct 2016
DAYTON, Ohio and INDIANAPOLIS, Oct. 10, 2016 (GLOBE NEWSWIRE) — CareSource, a non-profit health plan, announces that its Medicare Advantage plan service area in Indiana... Read More →
ZIOPHARM Presents Data Demonstrating Activation of Anti-Tumor Immune Response Using Ad-RTS-hIL-12 in Patients with Advanced Breast Cancer
/
Date10 Oct 2016
BOSTON, Oct. 10, 2016 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced the presentation of preliminary data from the Company’s Phase 1b/2 study of Ad-RTS-hIL-12... Read More →
Rexahn Pharmaceuticals Presents Preliminary Efficacy Data from Phase Ib/IIa Trial of RX-3117 in Metastatic Pancreatic Cancer and Supinoxin™ Phase I Trial at 2016 European Society for Medical Oncology (ESMO) Congress
/
Date10 Oct 2016
RX-3117 showed Preliminary Efficacy in Pancreatic Cancer Patients for Whom Three or More Prior Therapies had been Ineffective Supinoxin™ was Safe and Well Tolerated in... Read More →
Clearside Biomedical, Inc. to Report Clinical Trial Results at 2016 Retina Sub-Specialty Day Meeting at the American Academy of Ophthalmology (AAO) Meeting
/
Date10 Oct 2016
Phase 2 Results in the Treatment of Macular Edema Associated with Retinal Vein Occlusion Phase 2 and Phase 1/2 Results in the Treatment of Macular... Read More →
Galena Biopharma to Present NeuVax™ (nelipepimut-S) plus Trastuzumab Interim Safety Data at the European Society for Medical Oncology (ESMO) 2016 Congress
/
Date10 Oct 2016
SAN RAMON, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and... Read More →
Cascadian Therapeutics Announces Presentation of Tucatinib in Combination Therapy in Patients with Cutaneous HER2+ Metastatic Breast Cancer
/
Date10 Oct 2016
SEATTLE, Oct. 10, 2016 (GLOBE NEWSWIRE) — Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the presentation of clinical activity of tucatinib, its investigational,... Read More →
Endocyte Presents Data on Two Lead Clinical Programs at European Society for Medical Oncology (ESMO) 2016 Congress
/
Date10 Oct 2016
WEST LAFAYETTE, Ind., Oct. 10, 2016 (GLOBE NEWSWIRE) — Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging... Read More →
The Center Develops Software to Strengthen Future Workforce
/
Date10 Oct 2016
CLEVELAND, Oct. 10, 2016 (GLOBE NEWSWIRE) — In an effort to help strengthen the future workforce in Northeast Ohio and beyond, The Center for Health... Read More →
Published studies in humans and mice reveal how a superior vitamin B3 may play an important role in helping us enjoy longer, healthier lives
/
Date10 Oct 2016
IRVINE, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) — ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for... Read More →